Tagged with “sigmoidoscopy”

Archives

One-Time Flex Sig Cuts Colorectal Cancer Deaths

One flexible sigmoidoscopy screening between the ages of 55 and 64 reduced both colorectal cancer diagnoses and deaths during a randomized clinical trial in the United Kingdom.

After following 170,000 people for more than 11 years, deaths from colorectal cancer were 43 percent lower among those who had a flexible sigmoidoscopy screening.  Diagnosis of colorectal cancer was reduced by 33 percent.

This is the first prospective clinical trial that actually proved that examining the rectum and colon with a scope could reduce colorectal cancer deaths. Continue reading…

Posted by Kate Murphy on April 30th, 2010
Posted in: Research & Treatment News | No Comments »
Tags: colorectal cancer screening, sigmoidoscopy, UK sigmoidoscopy screening trial

Search C3

Free Patient Webinar

Stage II Colon Cancer: Chemo or Not? Find Your Solution
Monday, September 20, 2010
8:00 PM - 9:00 PM EDT

Stage II colon cancer patients face tough decisions about whether the possible benefits of chemotherapy outweigh its risks and challenges. This webinar will explore the answers with you.

Register Now

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

C3 Store

Order pins, bracelets and other materials

Order Now

Shop for the Cause

Buy a camera and help fight colorectal cancer.

Shop Now

Get Momentum

Summer 2010 issue available now.

Download Now

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe

Is Your Butt Covered?

Accreditation

We comply with the HONcode standard for trustworthy health information:
verify here.